52 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
VLS
Vita Life Sciences
AU$1.85-5.1%-3.1%AU$102.9mn/aPE11xn/a4.9%
EZZ
EZZ Life Science Holdings
AU$1.98-1.5%256.8%AU$93.4mAU$5.45PE13.4xE17.9%1.5%
ACR
Acrux
AU$0.031-3.1%-49.2%AU$12.5mAU$0.11PS2.4xE91.8%0%
MVP
Medical Developments International
AU$0.6655.3%-21.9%AU$74.4mAU$3.33PS2.2xE91.2%0%
BOT
Botanix Pharmaceuticals
AU$0.441.1%137.8%AU$803.3mAU$0.65PS388.2xE99.4%n/a
BDX
BCAL Diagnostics
AU$0.1010.2%13.9%AU$36.8mAU$0.20PS11.9xE90.6%n/a
ARX
Aroa Biosurgery
AU$0.56-8.3%-6.7%AU$191.4mAU$0.85PS2.8xE60.4%n/a
ECS
ECS Botanics Holdings
AU$0.014-3.4%-46.2%AU$18.0mn/aPE9.4xn/an/a
PER
Percheron Therapeutics
AU$0.008-11.1%-89.2%AU$8.7mAU$0.01PS2.9xE-37.2%n/a
MSB
Mesoblast
AU$3.02-1.0%1,061.5%AU$3.8bAU$2.69PS408.2xE55.0%n/a
CYP
Cynata Therapeutics
AU$0.2414.0%69.0%AU$55.2mAU$0.83PS23.8xE72.9%n/a
ACW
Actinogen Medical
AU$0.03114.8%0.003%AU$97.1mn/aPS9.8xE-22.1%n/a
IMC
Immuron
AU$0.076-5.0%4.1%AU$17.7mAU$0.29PS3.6xE22.4%n/a
NSB
NeuroScientific Biopharmaceuticals
AU$0.048.1%8.1%AU$5.8mn/aPE17.8xn/an/a
ATH
Alterity Therapeutics
AU$0.01250.0%140.0%AU$63.8mAU$0.036PS15.9xE-20.4%n/a
ALA
Arovella Therapeutics
AU$0.205.4%30.0%AU$206.6mAU$0.33PS105.8xE47.2%n/a
MYX
Mayne Pharma Group
AU$4.600%-14.0%AU$373.7mAU$6.10PS1xE111.4%n/a
GSS
Genetic Signatures
AU$0.57-7.3%15.0%AU$130.6mAU$1.05PS9.5xE74.5%n/a
CHM
Chimeric Therapeutics
AU$0.0060%-76.0%AU$9.5mn/aPS1.3xn/an/a
1AI
Algorae Pharmaceuticals
AU$0.006-14.3%-40.0%AU$10.1mn/aPS80.9xn/an/a
RAD
Radiopharm Theranostics
AU$0.024-7.7%-63.1%AU$55.3mAU$0.25PS28.3xE44.1%n/a
PAB
Patrys
AU$0.0025-16.7%-68.8%AU$5.1mn/aPS3.7xn/an/a
NUZ
Neurizon Therapeutics
AU$0.1411.5%-19.4%AU$71.3mAU$0.56PS84.7xS58.2%n/a
ATX
Amplia Therapeutics
AU$0.0830%3.8%AU$28.8mn/aPS8.4xn/an/a
Page 1 of 3